Legal News

Teva to Cut 5,000 Pharma Jobs
Download PDF
1 Star2 Stars3 Stars4 Stars5 Stars (No Ratings Yet)

Teva makes good medicine! Teva Pharmaceutical Industries Ltd. will cut around 5000 employees by next year as it restructures and becomes more flexible in the marketplace. Downsizing when it needs to, will allow the company to move quickly in and out of opportunities without heavy and weighty costs like employee labor-relation-health-benefit/pension headaches. In other words, the firm will become slimmer and more efficient.

Israel based Teva employs around 46,000 people around the globe, so this cut will be about a 10 percent reduction in its global workforce. According to Yahoo Finance, “The drug maker plans to trim oversized parts of its business while growing its generic and core research and development programs.” So far the Pharma giant plans on reinvesting whatever monies are saved from the employee cuts and piping those into “high potential areas, such as the development of complex generics and specialty pharmaceutical products.”


Teva at this time seeks to expand its emerging markets presence, as well as expand its product line in its portfolio of offerings. The over-the-counter segment is especially one that will be focused on for expansion. Places that will have a special draw will be China and Brazil, both with huge populations and growing emerging market economies with expanding income and growing health care segments, which will also trigger a growth in pharmaceutical demand.

While Teva has its eyes on the emerging market growth, it also will close two plants in the United States. By 2017 a plant in Sellersville, Pa, producing generic drugs with an employee population of 450 will be closed. Another plant in Irvine, California will be sold. Teva plans its global restructure where it will save about $2 billion dollars by 2017. The company mentions that a reduction in its accounting item cost of goods sold is expected. Teva also forecasted $20.5 billion in revenue by the end of 2013, as analysts expect the pharmaceutical company’s earnings to be at $4.00 per share, according to the research-data firm FactSet.

As one of the world’s largest creator of drugs, Teva is seeking to have its own brand as a part of its business. So while certain jobs are being cut at this time in some segments of its business, the company has many plans and projects to grow and expand in different directions as well as into new markets. Over this past year, Teva shares have traded between $36.63 and $42.83; today’s trading left the share at $40.57.

Get JD Journal in Your Mail

Subscribe to our FREE daily news alerts and get the latest updates on the most happening events in the legal, business, and celebrity world. You also get your daily dose of humor and entertainment!!



Family Law Attorney


What does an Attorney do at MFL? Perform consultations with potential clients and retain them ...

Apply now

Associate Attorney

USA-CA-Newport Beach

Smith Smith & Feeley LLP is an AV-rated law firm located in Newport Beach, California, with a specia...

Apply now

Family Law Attorney

USA-CA-San Jose

Why we think we’re the best… Here are some highlights of our amazing culture, perks, ...

Apply now

Immigration Attorney

USA-LA-New Orleans

  Maria Cordero --   A Law firm in Gretna, LA is looking for an Immigration at...

Apply now




Search Now

Mid-level Corporate Associate Attorney


Napa office of a BCG Attorney Search Top Ranked Law Firm seeks a mid-level corporate associate attor...

Apply Now

Liability Defense Attorney

USA-FL-Fort Lauderdale

Ft. Lauderdale office of our client seeks liability defense attorney with 3+ years of insurance defe...

Apply Now

Litigation Associate Attorney

USA-CA-San Francisco

San Francisco office of a BCG Attorney Search Top Ranked Law Firm seeks litigation associate attorne...

Apply Now

Most Popular


To Top